APOLLOHOSP

📉 Promoter & Stake Activity

📊 Stock Performance & Market Data Apollo Hospitals shares are trading roughly around ₹7,080–₹7,290 recently, with some weekly declines seen in returns amid broader market volatility. Price-to-earnings (P/E) ratios remain high relative to many peers, indicating valuation expectations for continued growth. The 52-week range shows the stock fluctuating between roughly ₹6,000 at the low and above ₹8,000 at the high, reflecting significant price movement over the year. 🧑‍⚕️ Business & Expansion Apollo Hospitals continues to execute a long-term expansion plan, adding beds and scaling capacity across its hospital network. The company has also moved to restructure and demerge certain businesses — notably its omnichannel pharmacy and digital health arms — into separately listed entities to unlock shareholder value. There are ongoing efforts to acquire stakes in subsidiaries, enhancing control over retail healthcare segments. 📈 Earnings & Financials The company reported strong quarterly results in FY26, with healthy revenue growth and a double-digit profit increase year-on-year. Core healthcare services, pharmacy operations, and digital health units have collectively contributed to improved overall profitability. 📉 Promoter & Stake Activity There have been block deal sales by key promoters/management, which briefly influenced market sentiment at that time.